{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Foncologypodcast.simplecast.com%2Fepisodes%2Fanti-tigit-therapy-px1r93ON","width":444,"version":"1.0","type":"rich","title":"Anti-TIGIT Therapy: Overview of Current Clinical Evidence and Key Ongoing Trials","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/59987882-aa7a-43c4-995f-5f6624823f30/multi-tumor-tigit-podcasticon.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/1d3709c0-d5bb-471b-86f7-58b8320d4199\" height=\"200\" width=\"100%\" title=\"Anti-TIGIT Therapy: Overview of Current Clinical Evidence and Key Ongoing Trials\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"Listen to Dr. Jyoti D. Patel and Dr. Ani Balmanoukian as they discuss the potential role of anti-TIGIT therapies in lung cancer and other solid malignancies."}